Friday, July 30, 2021

THE CASE OF FAUCI - Bureaucrat Term Limits NEEDED

 ROGER SIMON ON 

THE CASE OF FAUCI: Why Bureaucrats Need Term Limits More Urgently than Politicians.

Just the other day, he was seeming to wobble under withering examination from Sen. Rand Paul (R-Ky.) over the NIAID director’s relationship, including possible funding, with the Wuhan Institute of Virology from emails recently exposed via a Freedom of Information Act request.

This points to the extraordinary danger posed by Fauci and other unelected bureaucrats who, due to years of basically unsupervised activity, make decisions that affect foreign policy as greatly as presidents.

What could be more alarming than the funding or sponsoring of gain-of-function research in communist China by American taxpayers?

Was the doctor not aware of information that is publicly available, such as this report from Japan Forward: “Biological Weapons the Focus of China’s Military Research in the Last 20 Years.”

In a way, we can read Fauci’s strangely erratic behavior over the past couple of years, including disagreeing with Trump over the then-president’s decision to block travel from China at the beginning of the pandemic, as an attempt to evade scrutiny of his relationship with the communist Chinese.

To this day, he’s avoiding answering questions on this relationship that could end up linking him to some of the most heinous research ever conducted, both abroad and, alas, at home.

Fauci himself could have what the French call “mains sales” (dirty hands) in the horrifying global tragedy that has transpired and is continuing to plague us.

Or not.

But what is he hiding and why are we, the citizens of a supposedly free country, prey to his edicts?

Speaking personally, I took the Pfizer shots and now wonder if I should have, as it becomes more clear that the death rates for healthy people are exceptionally low, even for 70- and 80-year-olds, and that readily available drugs like ivermectin and hydroxychloroquine work just as well, most probably better, than the vaccinations, to keep us healthy.

But someday this will end, or more likely be abated, and something else will come up. For that reason, term limits for the bureaucracy should be at the top of the agenda when the Republicans next hold the presidency and the Congress.

No more Faucis, please.

Endorsed.

Related: No, Karen, we’re not masking again: A winning GOP message for 2022 & beyond.

S

Thursday, July 29, 2021

China Cracks Down on Big Tech

 Beijing calls for calm after historic tech stock rout.


 “Chinese state-run newspaper Securities Times published a commentary Wednesday acknowledging the ‘changes in policy for certain industries’ after a market rout on Monday and Tuesday that came as investors reacted to Beijing’s widening crackdown on private enterprise.”



Beijing calls for calm after historic tech stock rout

Hong Kong (CNN Business)Chinese state media is urging investors to stay calm following a brutal stock market sell-off this week that has wiped out hundreds of billions of dollars in value.

Chinese state-run newspaper Securities Times published a commentary Wednesday acknowledging the "changes in policy for certain industries" after a market rout on Monday and Tuesday that came as investors reacted to Beijing's widening crackdown on private enterprise.
"Investors should have confidence in the market," it wrote. "A short-term shock does not change the nature of the long-term positive trend ... China's economy and markets are at an advantage in terms of its width and depth."
    Even so, Chinese tech stocks swung wildly Wednesday.
      Tencent (TCEHY) shares closed flat after news that the company's WeChat messaging platform would temporarily suspend all new user registrations to comply with regulations relating to an upgrade of its security systems. It had earlier fallen as much as 6.4%, before paring most of those losses.
          Meantime, the Hang Seng Tech Index, a Nasdaq-like index that tracks the largest tech firms trading in the city, closed up 3.1%, while Meituan and Alibaba (BABA) each rebounded 7.5% and 1.8%, respectively.
          Each had seesawed throughout the day, at one point posting declines of between roughly 2% and 3%.
          Monday and Tuesday had been Meituan's two worst days on record. The company shed more than $62 billion in market cap after regulators issued guidelines Monday calling for improved standards for food delivery workers. Meituan runs one of China's biggest food delivery platforms, with hundreds of millions of users making transactions on its app annually.
          Tencent also recorded its worst day in about a decade on Tuesday, losing more than $100 billion in market value. The losses came after it was ordered by regulators over the weekend to scrap its plan to acquire another music streaming player, China Music Corporation. The WeChat announcement came on top of that, dealing another blow.
          Altogether, three of China's most valuable companies — Tencent, Meituan and Alibaba — lost more than $237 billion through the first two days of trading this week. That's not even accounting for the stocks of Chinese tutoring firms, which were slammed after officials announced a clampdown on the country's fast-growing education sector.
          This week's sell-off in Hong Kong will go down as one of the biggest in history, according to Bespoke Investment Group.
          "Since the end of the financial crisis, there hasn't been a single two-day decline in the Hang Seng that has exceeded the magnitude of the last two days," the firm wrote in a note to clients Tuesday, referring to the city's benchmark index.
          Still, there could be "potential for a short-term bounce" as investors "look for opportunity in the weakness," it added.

          A long shadow

          In recent months, China's tech industry has suffered a series of regulatory body blows. Before this week's plunge, shares of overseas-listed Chinese tech firms had already lost a staggering $1 trillion in value between February and mid-July, according to Goldman Sachs analysts.
          Now, that is spreading as China's clampdown continues to ripple across sectors.
          In the investing community, there are growing concerns that Chinese companies may be deterred from going public in the United States, particularly after new requirements for those looking to list their shares overseas and a disastrous initial public offering in New York by Didi (DIDI).
          The ride-hailing giant made a splash last month in the biggest US IPO by a Chinese company since Alibaba's (BABA) debut in 2014, raising some $4.4 billion.
          But just days after the fanfare, Didi's shares crashed as Beijing launched a probe into the company and suspended the registration of new users on its flagship app.
          Since then, several Chinese firms have backed away or reportedly reconsidered plans to list in the United States. TikTok owner ByteDance, social e-commerce platform Xiaohongshu, fitness app Keep and medical data company LinkDoc Technology have all either shelved or scrapped plans to list in New York, according to reports by Bloombergthe Wall Street Journal and the Financial Times. (ByteDance declined to comment on those reports, while the rest did not respond to requests for comment last week.)
          On Tuesday, Chinese bike-sharing startup Hello (formerly known as Hellobike) shelved plans for a US IPO it had filed for just months ago.
          The Shanghai-based firm, which is backed by Alibaba-affiliate Ant Group, had been planning to raise up to $100 million.
          Hello did not specify why it had chosen to step back from the share sale. In a regulatory filing, it simply said that "it no longer wishes to conduct a public offering of securities at this time."
            But it alluded to regulatory constraints in a later statement, saying: "We will continue to operate under national supervision and its regulations, as well as the requirements of a capital market environment, and pursue an IPO in a timely manner."
            — CNN's Hong Kong bureau contributed to this report.